36
Views
0
CrossRef citations to date
0
Altmetric
Rapid Communication

Chemical Composition and Anticholinesterase Inhibitory Activity of Essential Oils from Magnolia villosa (Miq.) H.Keng. and Magnolia maingayi King. Leaves

, , &
Pages 486-492 | Received 26 Feb 2023, Accepted 11 Apr 2023, Published online: 11 Jun 2023
 

Abstract

This study aimed to investigate the chemical compositions of the leaf essential oils of Magnolia villosa (Miq.) H. Keng. and M. maingayi King. growing in Malaysia. The leaf essential oils were obtained by hydrodistillation and fully characterized by gas chromatography and gas chromatography-mass spectrometry. Analysis of M. villosa and M. maingayi leaf essential oils resulted in 96.4% and 98.7% of the total essential oil, respectively. The main components of M. villosa leaf essential oil were β-caryophyllene (32.8%) and α-humulene (8.8%), while in M. maingayi leaf essential oil gave β-elemene (27.4%), β-caryophyllene (16.4%), and (E)-nerolidol (14.4%). Anticholinesterase inhibitory activity was also evaluated using acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory assays. M. villosa leaf essential oil revealed a moderate inhibitory effect on AChE (percentage inhibition, I%: 62.5%) and BChE (I%: 74.8%) at a concentration of 1,000 μg/mL. In conclusion, the leaf essential oils of M. villosa and M. maingayi were characterized and showed promising anticholinesterase inhibitory activity, suggesting their potential as natural sources of therapeutic agents for managing cholinergic dysfunction-related diseases.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.